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Abstract
G Protein Coupled Receptors (GPCR) can form dimers or higher ordered oligomers, the process of which can remarkably
influence the physiological and pharmacological function of these receptors. Quantitative Bioluminescence Resonance
Energy Transfer (qBRET) measurements are the gold standards to prove the direct physical interaction between the
protomers of presumed GPCR dimers. For the correct interpretation of these experiments, the expression of the energy
donor Renilla luciferase labeled receptor has to be maintained constant, which is hard to achieve in expression systems. To
analyze the effects of non-constant donor expression on qBRET curves, we performed Monte Carlo simulations. Our results
show that the decrease of donor expression can lead to saturation qBRET curves even if the interaction between donor and
acceptor labeled receptors is non-specific leading to false interpretation of the dimerization state. We suggest here a new
approach to the analysis of qBRET data, when the BRET ratio is plotted as a function of the acceptor labeled receptor
expression at various donor receptor expression levels. With this method, we were able to distinguish between dimerization
and non-specific interaction when the results of classical qBRET experiments were ambiguous. The simulation results were
confirmed experimentally using rapamycin inducible heterodimerization system. We used this new method to investigate
the dimerization of various GPCRs, and our data have confirmed the homodimerization of V2 vasopressin and CaSR calcium
sensing receptors, whereas our data argue against the heterodimerization of these receptors with other studied GPCRs,
including type I and II angiotensin, b2 adrenergic and CB1 cannabinoid receptors.
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Introduction
G Protein Coupled Receptors (GPCRs) were thought to be
monomeric entities for a long time, but results of the last two
decades indicate that they can form dimers or higher ordered
oligomers [1]. Dimerization can alter the ligand binding and active
conformation of the receptors, and also the interactions with
different effector proteins such as heterotrimeric G proteins and b-
arrestins. The effects of dimerization on receptor signaling are
proposed to have great physiological and pharmacological
consequences [2–4]. While the dimerization of Class C GPCRs,
including GABAB receptors is widely accepted [5], the occurrence
and functional consequences of rhodopsin like Class A GPCR
dimerization are more controversial. However, large amounts of
data argue that Class A GPCRs can also form dimers, even in
native tissues [6,7], and this dimerization has important effects on
receptor function [8,9].
A wide range of approaches has been used to prove the direct
physical interactions between the protomers of a presumed dimer.
While some elegant new methods, such as analysis of receptor
mobility [10] and visualization of single fluorescently labeled
receptors on cell surface [11] are currently available, the current
gold standard to study the quaternary structure of GPCRs is the
method of quantitative Bioluminescence Resonance Energy
Transfer (qBRET) [12,13].
In qBRET experiments the protomers of the presumed dimer
are labeled with the energy donor Renilla luciferase (Rluc) and an
energy acceptor fluorescent protein, respectively. Although the
energy donor in BRET is the oxidation of coelenterazine h, the
substrate of Rluc, for simplicity we will refer to Rluc as the energy
donor in this article. The measured energy transfer is highly
sensitive to the distance between donor and acceptor, so BRET
ratio (calculated by emission at 530 nm/emission at 485 nm) can
be excellently used to monitor protein-protein interactions, such as
dimerization. BRET is ideal to measure changes of protein-protein
interactions (e.g. binding of effector molecules to an activated
receptor [14]), however measuring static interactions is more
complicated. Labeled plasma membrane proteins can produce
measurable BRET signals due to overexpression and random
collisions even in the absence of dimerization. To distinguish
between specific interaction (dimerization) and non-specific
interaction, in qBRET experiments constant amount of donor
labeled receptor is coexpressed with increasing amount of acceptor
labeled receptor, and the BRET signal is plotted as a function of
acceptor/donor expression ratio [12,13]. In the case of specific
interaction a saturation curve is observed, while non-specific
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interaction results in a linear relationship. While some recent
articles suggest, that qBRET curves must be critically interpreted
[15–17], qBRET experiments are still the most widely used
method to study GPCR oligomerization.
In this study, we performed classical qBRET experiments to
investigate the dimerization of various GPCRs. We observed
saturation qBRET curves between the majority of receptor pairs,
but also found, that maintaining a constant expression of donor
labeled receptors is hard to achieve in a transient transfection
system. We performed Monte Carlo simulations to investigate the
effects of non-constant donor expression on qBRET curves. We
found, that the changes of donor levels can lead to saturation
qBRET curves also in the absence of dimerization. To verify our
simulation results, we performed qBRET experiments with
varying donor expression levels in a rapamycin inducible
heterodimerization system. Based on our simulation and experi-
mental results we suggest a new method to perform and analyze
qBRET experiments. With these changes, we were able to
investigate the dimerization state of different GPCRs.
Materials and Methods
Materials
Molecular biology enzymes were obtained from Fermentas
(Vilnius, Lithuania) and Stratagene (La Jolla, CA). The cDNA of
the human arginine vasopressin receptor 2 was purchased from
S&T cDNA Resource Center (Rolla, MO, USA). Cell culture
dishes and plates for BRET measurements were purchased from
Greiner Bio-One GmbH (Kremsmunster, Austria). Cell culture
media, Lipofectamine 2000 and coelenterazine h were purchased
from Invitrogen (Carlsbad, CA). Rapamycin was obtained from
Merck (Darmstadt, Germany). HEK293 cells were from American
Type Culture Collection (Manassas, VA).
Plasmid constructs
To create RLuc and Venus tagged human V2 vasopressin
receptor (AVPR2, Entrez Gene ID: 554), first the receptor
sequence was amplified from cDNA clone, purchased from S&T
cDNA Resource Center (Rolla, MO, USA). Then the receptor
sequence was subcloned using EcoRI and AgeI restriction
enzymes into pEYFP-N1 vector containing super Renilla lucifer-
ase [18] or monomeric Venus [19,20] respectively. To create
RLuc and Venus tagged human CaSR calcium sensing receptor
(CASR, Entrez Gene ID: 846) construct, first the receptor
sequence was amplified from pcDNA3.1 plasmid [21], and then
was subcloned using HindIII and AgeI restriction enzymes into
pEYFP-N1 vector containing super Renilla luciferase [18] or
monomeric Venus [19,20] respectively. For the plasma membrane
targeting of PM2-FKBP-RLuc, we used the N-terminal palmitoy-
lation/myristoylation signal of the Lyn protein (MGCIKSKGKD-
SAGA). To create this construct, the fluorescent protein of PM2-
FKBP-mRFP [22] was replaced with super Renilla luciferase [18].
For the plasma membrane targeting of Venus-FRB-CAAX, we
used the C-terminal CAAX motif of kRas protein
(KMSKDGKKKKKKSKTKCVIM). To create this construct,
first the C-terminal ER localization sequence of SacI phosphatase
in CFP-FRB-ER(SacI) [22] was replaced with the sequence of
kRas CAAX motif from KR-YFP [23]. Then the fluorescent
protein was replaced with monomeric Venus [19,20]. The
creation of Venus tagged rat AT1a angiotensin receptor (Agtr1a,
Entrez Gene ID: 24180), human b2 adrenergic receptor (ADRB2,
Entrez Gene ID: 154) and rat CB1 cannabinoid receptor (Cnr1,
Entrez Gene ID: 25248) were previously described [24]. Venus
tagged rat AT2 angiotensin receptor (Agtr2, Entrez Gene ID:
24182) was created by exchanging the sequence of eYFP in
AT2R-YFP [25] to the sequence of monomeric Venus [19,20].
For the expression of cytoplasmic Venus fluorescent protein,
pEYFP-N1 vector (Clontech, Mountain View, CA, USA),
containing the monomeric Venus sequence was used.
Cell culture and transfection
The experiments were performed on Human Embryonic
Kidney 293 (HEK293) cells. Cells were maintained in Dulbecco’s
Modified Eagle Medium (DMEM) supplemented with 10% bovine
serum, 100 mg/ml streptomycin and 100 IU/l penicillin in 5%
CO2 at 37uC. Cells were cultured in plastic dishes and were
trypsinized prior to transfection. For transient transfection, cells
were plated on poly-lysine-pretreated white 96-well plates at
0.756105 cells/well densities with 0.5 mg/well total plasmid and
0.5 ml/well Lipofectamine 2000.
Monte Carlo simulations
Simulations were performed on a 2 dimensional membrane
lattice containing 1006100 hexagons with periodic boundary
conditions. Monomers of donors and acceptors were randomly
placed on the empty hexagons of lattice. Total number of
molecules was varied from 200 to 2000. The molecules were
moved in each simulation step. For each monomer molecule a
random neighboring hexagon was selected to move to. If the
selected hexagon was occupied with another molecule, move was
rejected, and not repeated. For moving dimers, both protomers
had to arrive onto a free hexagon, and falling apart of dimers was
not allowed during a move step. Generally, dimers were allowed to
move to the same direction and/or rotate around each other.
Besides moving, monomers could form dimers and dimers could
fall apart into monomers in each simulation step. For each
monomer molecule one neighbor was randomly selected (if there
was any), and the two molecules could form a dimer with a
passociation probability depending in the type molecules. Dimers
could dissociate in each time step with a probability pdissociation,
also depending on the protomers of the dimer. Simulation was
performed for 1000 time steps, and BRET values were calculated.
Simulated BRET values were calculated as total neighboring
donor-acceptor pairs/number of donor molecules. Each simula-
tion was repeated five times. Simulations were written in Python
2.7. Source code is available online.
BRET measurements
BRET measurements were performed 24–28 hours after
transfection. Medium of the cells was changed to a modified
Krebs-Ringer buffer containing 120 mM NaCl, 4.7 mM KCl,
1.2 mM CaCl2, 0.7 mM MgSO4, 10 mM glucose and 10 mM
Sodium-Hepes, pH 7.4. Measurements were performed in a
Varioskan Flash Multimode Reader (Thermo Scientific, Waltham,
MA). Venus fluorescence (excitation 510 nm, emission 530 nm)
was measured at the beginning of each experiment. Coelenter-
azine h was added at 5 mM final concentration, and total
luminescence, luminescence at 485 nm and luminescence at
530 nm were recorded. Intensity ratio was defined as Venus
fluorescence/total luminescence. Intensity ratio does not show
directly the acceptor/donor ratio, but is proportional with it. From
the signals of cells expressing the same amount of RLuc and Venus
labeled construct, we approximated that the 1.0 intensity ratio
represents an acceptor/donor ratio 1:1. BRET ratio was
calculated as Emission530/Emission485. The BRET ratio of only
donor expressing cells was subtracted from the BRET ratio of
measured points. In the inducible dimerization experiments,
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100 nM rapamycin or vehicle DMSO was added to the cell
medium 30 minutes prior the measurements.
Figures, statistical analysis
Figures, curve fitting and statistical analysis were performed in
GraphPad Prism. All measurements were repeated from n= 3 to 8
(different transfections), and pooled data were plotted. For GPCR
Figure 1. Classical qBRET experiments. (A) Schematic representation of qBRET experiments (based on [12]): In qBRET experiments, constant
amount of energy donor labeled receptor is coexpressed with increasing amount of acceptor labeled receptor. BRET ratio is plotted as a function of
acceptor/donor expression ratio (left panel). Theoretically specific interactions result in a saturation curve (red and green), while non-specific
interaction shows linear relationship (blue). The absolute value of BRET ratio is not indicative of the dimerization state of the receptors, therefore
BRET50 value (acceptor/donor ratio at half-maximal BRET ratio) is used to determine the affinity of receptors to form dimers (which is the same for red
and green curve, indicating the same likelihood of dimerization despite the different BRETmax values). To correctly interpret qBRET curves, donor
labeled receptor expression has to be maintained constant with increasing acceptor expression (right panel). (B) HEK293 cells were transiently
transfected with a constant amount V2R-RLuc (donor) coding plasmid and with increasing amounts of either AT1R-Venus, b2AdR-Venus, CB1R-Venus,
V2R-Venus or cytoplasmic Venus (acceptor) coding plasmid. Various amounts of empty pcDNA3.1 plasmid was added to maintain constant total
transfected plasmid amount. Total luminescence and Venus fluorescence were measured at the beginning of each experiment, and intensity ratio
was calculated as fluorescence/total luminescence. Intensity ratio shows not the absolute acceptor/donor expression ratio (see Methods for further
details) but is proportional with it. BRET ratio was calculated as Emission530/Emission485, and was plotted as a function of intensity ratio (left panel).
Measured total luminescence was plotted as a function of measured fluorescence for the investigated donor - acceptor pairs (right panel). Curves
were fitted using non-linear regression equation assuming a single binding site (GraphPad Prism). n = 3.
doi:10.1371/journal.pone.0109503.g001
Table 1. Calculated BRETmax and BRET50 values for classical qBRET experiments.
Acceptor AT1R b2AdR CB1R V2R cVenus
BRETmax 0.068 0.083 0.059 0.457 0.088
+/20.003 +/20.002 +/20.005 +/20.010 +/20.011
BRET50 0.985 1.092 0.962 2.903 26.220
+/20.116 +/20.100 +/20.192 +/20.163 +/26.186
BRETmax and BRET50 values were calculated for experimental data (Figure 1B, left panel) using a non-linear regression equation assuming a single binding site (GraphPad
Prism). Data are given as best fit value +/2 Std. Error.
doi:10.1371/journal.pone.0109503.t001
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dimerization experiments slope of the linear regression for
different GPCR pairs was determined for low and high donor
expressions, and the difference between slopes was determined by
analysis of covariance (ANCOVA). *** indicates significant (p,
0.001) difference of slope between the low and high amount donor
expressing cells.
Results
Analysis of the dimerization of GPCRs using classical
qBRET experiments
In classical qBRET experiments, cells are transfected with
constant amount of plasmid coding donor labeled receptor, and
increasing amount of plasmid coding acceptor labeled receptor
[12,13]. To maintain equal transfection efficacy, total transfected
plasmid amount must also be held constant, with the addition of a
non-coding plasmid. The measured BRET ratio is plotted as a
function of acceptor/donor expression ratio. In this plotting,
specific interactions result in a saturation curve, while non-specific
interactions lead to a linear relationship (Fig. 1A, left panel). The
absolute value of BRET ratio is also dependent on the distance
between donor and acceptor in the quaternary complex, so it is
not thought to be indicative about the oligomerization state.
Therefore the so called BRET50 value (acceptor/donor ratio at
half-maximal BRET value) is used to determine the presence of
dimerization: in experiments conducted with one donor and
different acceptor labeled receptors, pairs with low BRET50 value
thought to form oligomers, while high BRET50 values indicate
weak interaction or the absence of interaction between the
investigated receptors. To correctly interpret qBRET curves, it is
necessary to hold constant the donor labeled receptor expression,
independent of the expression of acceptor labeled receptors
(Fig. 1A, right panel).
We investigated the dimerization of V2 vasopressin receptor
(V2R) with type I angiotensin receptor (AT1R), b2 adrenergic
receptor (b2AdR), CB1 cannabinoid receptor (CB1R) and V2R in
transiently transfected HEK293 cells. We also used cytoplasmic
expressed Venus protein as a negative control. Cells were co-
transfected with constant amount of Renilla luciferase labeled V2R
(V2R-RLuc) and increasing amount of the partner receptor
labeled with Venus fluorescent protein (AT1R-Venus, b2AdR-
Venus, CB1R-Venus and V2R-Venus, cVenus respectively). To
maintain transfected plasmid amount constant, empty pcDNA3.1
plasmid was added. The calculated BRET ratios were plotted as a
function of intensity ratio (measured fluorescence/measured total
luminescence), proportional with acceptor labeled receptor
expression/donor labeled receptor expression (Fig. 1B, left panel).
While the absolute values of BRET ratios were different, the
calculated BRET50 values for GPCR dimers were in the same
order of magnitude (Table 1). The BRET50 values indicate the
same ability of V2R to form dimers with AT1R, b2AdR and
CB1R, a lower ability to form homodimers and the absence of
specific interaction with cytoplasmic Venus protein. In these
experiments, despite the constant amount of transfected V2R-
RLuc plasmids, we observed a decrease of the measured
luminescence with increasing fluorescence levels (Fig. 1B, right
panel), indicating that maintaining constant donor labeled
receptor expression was not successful. To correctly analyze the
results of qBRET experiments, it is necessary to hold donor
labeled receptor expression constant, so we could not unambig-
uously determine the dimerization state of the investigated
receptor pairs.
Monte Carlo simulations to investigate the effects of
non-constant donor expression levels on qBRET curves
To analyze the effect of non-constant donor level on qBRET
curves, we performed Monte Carlo simulations. To simulate
dimerization, we used the model of Lindermann et al. [26,27] with
little modifications. Briefly, a membrane lattice containing
1006100 hexagons with periodic boundary conditions was
created, and monomers of donor and acceptor molecules were
randomly placed. The molecules could move and dimerize in each
time step of the simulation. If a monomer molecule had a neighbor
molecule, they could dimerize with a probability (passociation)
dependent of the types of the molecules. Dimers had a probability
(pdissociation) to fall apart in each simulation step, which is
dependent on the type of the dimer. After 1000 time steps,
simulated BRET ratios were calculated based on the number of
neighboring donor – acceptor pairs (donor acceptor pairs could be
formed by dimerization or by randomly moving a donor and an
acceptor molecule to neighboring hexagons). To specify the type of
interaction between donor and acceptor molecules we used
different passociation and pdissociation values (Table 2). A graphical
representation of our simulation experiments with a small
membrane piece is shown in Figure 2A. Further details of the
Monte Carlo simulations are found in Methods. In our
simulations, we varied both the number of donor and acceptor
molecules from 100 to 1000. We used two different representations
of the data: the simulated BRET ratio was plotted as function of
the number of acceptor molecules (Fig. 2B, Type I plots) or as
function of the acceptor/donor ratio (Fig. 2C, Type II plots, same
as classical qBRET plots). In the case of non-specific interaction
we found that the simulated BRET ratio is only dependent on the
amount of acceptor molecules (Fig. 2B, left panel), whereas the
amount of donor molecules has no influence on the BRET value.







Donor – Donor passociation = 0.0 passociation = 0.0
pdissociation = 0.0 pdissociation = 0.0
Donor – Acceptor passociation = 0.0 passociation = 1.0
pdissociation = 0.0 pdissociation = 0.0
Acceptor – Acceptor passociation = 0.0 passociation = 0.0
pdissociation = 0.0 pdissociation = 0.0
doi:10.1371/journal.pone.0109503.t002
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Figure 2. Monte Carlo simulations with various donor amounts. (A) Graphical representation of our simulations: two small membrane pieces
in the case of non-specific (left panel) and specific (right panel) interaction, ‘d’ and ‘a’ represents donor and acceptor molecules, respectively, while ‘2
‘ indicates empty hexagons. (B and C) Numbers of donor and acceptor molecules were varied from 100 to 1000 for each. BRET ratio was calculated
after 1000 simulation time steps based on the total number of neighboring donor-acceptor pairs. Simulated BRET ratio was plotted as a function of
the number of acceptor molecules (B) or acceptor/donor ratio (C). Simulations were performed with association and dissociation probabilities for
non-specific (left panels) and specific (right panels) interactions (Table 2). (D) Simulations performed for non-specific and specific interactions, when
total amount of donor and acceptor were fixed (insert). Curves were fitted using either linear regression or non-linear regression equation assuming a
single binding site (GraphPad Prism). n = 5, mean +/2 SEM.
doi:10.1371/journal.pone.0109503.g002
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Figure 3. Rapamycin inducible dimerization with various donor amounts. (A) Schematic representation of the rapamycin inducible
dimerization system: PM2-FKBP-RLuc (left molecule) and Venus-FRB-CAAX (right molecule) show non-specific interaction in the absence of rapamycin
(left panel), while the presence of rapamycin (right panel) results the dimerization of FKBP and FRB domains, converting the interaction into specific.
(B, C and D) HEK293 cells were transiently transfected with increasing amounts of PM2-FKBP-RLuc and Venus-FRB-CAAX, while empty pcDNA3.1
plasmid was added to maintain total transfected plasmid amount constant. Fluorescence-Luminescence plot (B) shows a wide and independent
distribution of acceptor and donor expression. Cells were treated with vehicle (left panels) or 100 nM rapamycin (right panels) 30 minutes prior to
measurements. Total luminescence and Venus fluorescence were measured at the beginning of each experiment, and intensity ratio was calculated
as fluorescence/total luminescence. BRET ratio was calculated as Emission530/Emission485, and was plotted as a function of measured fluorescence (C)
Quantitative BRET Analysis of GPCR Dimerization
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This phenomenon is reflected in Type II plots by the linear
relationship between acceptor/donor ratio and BRET ratio, but in
this case the slope of the linear regression is dependent on the
number of donor molecules (Fig. 2C, left panel). In the case of
specific interaction, the BRET ratio is dependent both on the
amount of acceptor and donor molecules. Type I plot (Fig. 2B,
right panel) shows that increasing the number of acceptors leads to
an increased BRET ratio, and this increase is reduced, when the
number of donor molecules is high. In Type II plot (Fig. 2C, right
panel) the BRET ratios show different saturation curves, which are
dependent on the donor amount. When data points were not
separated by donor expression in Type II plots, we could fit a
reasonable one-site specific binding curve for specific interaction
(R2= 0.95), while this was not possible for non-specific interaction
(R2= 0.49) (black dashed curve).
To model the reducing effect of increased acceptor expression
on donor expression (Fig. 1B, right panel), which caused problems
for the analysis of our initial classical qBRET experiments, we
performed simulations where the total amounts of donor and
acceptor molecules were held constant (Fig. 2D, insert). In this
case, specific and non-specific interactions both led to saturation
curves with nearly identical BRET50 values in Type II plots
(Fig. 2D). These data show that when donor expression decreases
with increasing acceptor expression, the dimerization state cannot
be determined using the classical presentation of qBRET curves.
The effects of non-constant donor expression levels on
qBRET curves in an inducible dimerization system
To experimentally verify our simulation results, we have taken
advantage of the well characterized rapamycin-induced dimeriza-
tion of FKBP and FRB protein domains [28]. Two non-
interacting plasma membrane markers, PM2 and CAAX were
labeled with FKBP/FRB and RLuc/Venus, respectively (PM2-
FKBP-RLuc and Venus-FRB-CAAX). We choose these markers,
because they are expressed in the plasma membrane, similar to
GPCRs. PM2 and CAAX has no basal interaction, since they are
or intensity ratio (D). Measured points were sorted into low/medium/high luminescence groups based on the measured total luminescence (B).
Curves were fitted using either linear regression or non-linear regression equation assuming a single binding site (GraphPad Prism). n = 3.
doi:10.1371/journal.pone.0109503.g003
Figure 4. Dimerization of V2 vasopressin receptor and CaSR calcium sensing receptor with various other GPCRs. HEK293 cells were
transiently transfected with increasing amounts of V2R-RLuc (A and B) or CaSR-RLuc (C) and with increasing amounts of either AT1R-Venus, AT2R-
Venus, b2AdR-Venus, CaSR-Venus, CB1R-Venus or V2R-Venus. Various amounts of empty pcDNA3.1 plasmid was added to maintain constant total
transfected plasmid amount. Total luminescence and Venus fluorescence were measured at the beginning of each experiment. BRET ratio was
calculated as Emission530/Emission485, and was plotted as a function of measured fluorescence. (A) Representative Type I plots for V2R-b2AdR
interaction (left plot) and V2R-V2R interaction (right plot). Measured points were sorted into low/high luminescence groups based on the total
measured luminescence (Figure S2). (B and C) The slope of linear regression was calculated for the low and high luminescence groups of different
GPCR pairs, and was plotted as a column diagram. Difference between the slopes of linear regression was determined by ANCOVA. n = 3–8.
doi:10.1371/journal.pone.0109503.g004
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localized in different plasma membrane microdomains [20]. In the
absence of rapamycin only non-specific interaction can be
observed, since the donor and acceptor do not interact (Fig. 3A,
left panel). Addition of rapamycin (100 nM, 30 min) leads to
dimerization of FKBP and FRB, which causes specific interaction
between the donor and acceptor molecules (Fig. 3A, right panel).
HEK293 cells were co-transfected with increasing amount of
PM2-FKBP-RLuc and Venus-FRB-CAAX coding plasmids, and
empty pcDNA3.1 plasmid to reach constant total transfected
plasmid amount. The amount of plasmids encoding donor and
acceptor proteins was independently varied (from 0.002 mg/well to
0.02 mg/well). In this way, we could reach a wide range of different
donor and acceptor expression levels (Fig. 3B). Measured points
were sorted into low, medium and high luminescence groups
based on the measured total luminescence (representing donor
expression). Similar to the presentation of our simulation results,
we used two representations of our experimental data. BRET ratio
was plotted either as a function of measured fluorescence,
representing acceptor expression (Fig. 3C, Type I plots) or as a
function of measured fluorescence/measured total luminescence
(Fig. 3D, Type II plots).
The experimental results were in good agreement with the
modeling data generated by Monte Carlo simulations. Type I plot
shows that in the case of non-specific interaction, the BRET ratio
is only dependent on the expression of acceptor labeled construct
(Fig. 3C, left panel). However, we found that in the case of specific
interaction, increasing the donor expression leads to flattening of
the qBRET curve (Fig. 3C, right panel). In Type II plots, we
found different linear and saturation curves for non-specific and
specific interaction, respectively (Fig. 3D). Similar to our simula-
tions, when the data points were not separated by donor
expression, we could fit a saturation curve on the specific
interaction data (R2= 0.89), but could not make this for non-
specific interaction (R2 = 0.23) in the Type II plots (black dashed
curve).
Figure 5. Preferred method to perform qBRET experiments. In Type I plots BRET ratio is plotted as a function of acceptor expression
(fluorescence), while in Type II plots BRET ratio is plotted as a function acceptor/donor expression (fluorescence/luminescence).
doi:10.1371/journal.pone.0109503.g005
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Modified qBRET experiments to analyze the dimerization
of GPCRs
Based on our simulation and experimental results, we analyzed
the dimerization of different GPCRs by a modified version of
classical qBRET experiments. Instead of trying to maintain
constant expression of the donor labeled receptor, we varied the
transfected amount of donor and acceptor labeled receptor as well,
to reach a wide range of different donor – acceptor expressions.
Based on our results, to distinguish specific and non-specific
interaction, it is more appropriate to plot BRET ratio as a function
of measured fluorescence (acceptor expression) (see Figure S1. for
further details). While classical qBRET experiments require high
level of acceptor expression to reach saturation curves, our method
allowed us to differentiate between specific and non-specific
interaction also at lower acceptor expression levels, on the initial
lineal phase of the curves. In the case of non-specific interaction,
BRET ratio is only dependent on the acceptor expression, and
independent of the donor expression, the measured BRET ratios
are on the same flat linear curve (Fig. 2B and 3C, left panels). In
the case of specific interaction the fluorescence-BRET ratio plot is
steeper, and the increase of donor expression leads to a flattening
of the curve (Fig. 2B and 3C, right panels).
We analyzed the dimerization of V2R and CaSR calcium
sensing receptor (a typical Class A and Class C GPCR,
respectively) with AT1R, type II angiotensin receptor (AT2R),
b2AdR, CaSR, CB1R and V2R. HEK293 cells were transfected
with increasing amount of donor (V2R-RLuc or CaSR-RLuc) and
acceptor (AT1R-Venus, AT2R-Venus, b2AdR-Venus, CaSR-
Venus, CB1R-Venus or V2R-Venus) labeled receptor coding
plasmid. Empty pcDNA3.1 plasmid was added to reach constant
total transfected DNA amount. Measured points were sorted into
low and high luminescence groups based on the measured total
luminescence, similarly to our inducible dimerization experiments
(Figure S2). BRET ratio was plotted as a function of measured
fluorescence. Figure 4A shows our results for the V2R- b2AdR (left
panel) and V2R-V2R (right panel) interaction. In the case of V2R-
b2AdR interaction, the Type I plot shows flat linear relationship;
where the donor expression does not influence the slope of the
linear regression, indicating the non-specific nature of this
interaction. In contrast, in the case of V2R-V2R interaction, the
curve is steeper, and the increase of donor expression leads to
flattening of the curve, showing the homodimerization of V2R. We
performed the same analysis for all of the investigated receptor
pairs (Figure S2), and plotted the slope of the linear regression also
for low and high amount of donor expression (Fig. 4B and 4C).
We found, that the slope of linear regression was low and the
donor expression did not influence the slope for all of the
investigated receptor pairs, except the V2R-V2R and the CaSR-
CaSR interaction. Our data indicate the homodimerization of
V2R and the homodimerization of CaSR, and the absence of
heterodimerization between the investigated receptors.
Discussion
Dimerization or oligomerization of receptors is an emerging
question of the GPCR field. Dimerization of GPCRs can alter the
binding and signaling of GPCRs, and is thus proposed to have
major physiological and pharmacological consequences. While
many functional data support the concept of dimerization,
evidence of direct physical interaction is crucial to declare the
dimerization of two GPCRs. The most widely used method for the
latter is the method of quantitative BRET.
In qBRET experiments constant amount of donor labeled
receptor is expressed, while the amount of acceptor labeled
receptor is increased [12,13]. When BRET ratio is plotted as a
function of acceptor/donor amount (Fig. 1A, left panel), specific
interaction (dimerization) leads to saturation curves, while non-
specific interaction results in a linear relationship (or saturation
curve with a high BRET50 value). The analysis of qBRET curves
supposes that with the increasing acceptor expression, the donor
expression does not change (Fig. 1A, right panel). In our classical
qBRET experiments, we found that all of the investigated pairs
resulted in saturation qBRET curves with BRET50 values of the
same magnitude, except for cytoplasmic Venus (Fig. 1B, left
panel). These data would indicate approximately the same ability
of V2R to form homodimer and heterodimers with the investigat-
ed receptors, and the absence of specific interaction between V2R
and cytoplasmic Venus. While cytoplasmic fluorescent proteins
were originally used [13] as negative controls for qBRET
experiments, they are absolutely not ideal controls: only a small
fraction of cytoplasmic proteins are in close proximity of the
plasma membrane to produce energy transfer signal, so the
‘‘effective’’ acceptor amount is much smaller than the total
acceptor amount estimated by measuring fluorescence. This
explains the phenomenon that cytoplasmic fluorescent proteins
are always resulting in flat qBRET curves. Despite this fact,
cytoplasmic proteins are still frequently used as negative controls
also nowadays [29].
We also found, that despite the constant amount of donor
labeled receptor coding plasmid in the transfection reaction, the
increase in acceptor expression leads to the decrease in donor
expression (Fig. 1B, right panel). In most of the related articles, the
constant expression of donor labeled receptors was only assumed
based on the constant amount of the donor labeled receptor
coding plasmid in the transfection reaction; however, in most cases
the actual expression levels were not shown explicitly. Also the
original article describing qBRET method states that ‘‘Although
the BRET saturation curves were carried out using a fixed
concentration of the RLuc fusion partners, co-transfecting an
increasing quantity of the GFP constructs introduces some levels of
variability in the amount of receptor-RLuc expressed in each case.
To rule out the influence of this variable, the BRET levels were
plotted as a function of the ratio between the receptor-GFP/
receptor-Rluc numbers’’ [13]. So it can be supposed, that the
decrease of donor expression was not only a problem in our
experiments, but a general problem of qBRET experiments.
We performed Monte Carlo simulations to investigate the
effects of these changes of donor expression on qBRET curves.
Simulations were performed in a membrane lattice containing
1006100 hexagons, where one receptor could occupy one
hexagon. The total numbers of receptors were varied between
200 and 2000 in the simulations. Assuming that the size of an
average cell is 50mm and the diameter of a GPCR is 5 nm, our
simulations represent approximately 106 receptors/cell, which are
normal values for an overexpression system. We found, that the
decrease of donor expression can lead to a saturation qBRET
curve also in the case of non-specific interaction (Fig. 2D), which
fact can lead to a false interpretation of dimerization state of the
investigated receptors. While the strictly inverse relationship
between donor and acceptor expression in this simulation seems
to be a bit of rigid condition, our classical qBRET experiments
showed similar expression alterations (especially for AT1R and
CB1R, Figure 1B, right panel).
Our simulations showed that the difference between non-
specific and specific interaction is less ambiguous when the donor
and acceptor amount is also altered, and the BRET ratio is plotted
as a function of acceptor amount (Fig. 2B). In this presentation,
non-specific interaction leads to a flat linear curve, and the amount
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of donor molecules does not influence the BRET ratio (Fig. 2B,
left panel). At the first impression this phenomenon was surprising,
but it is easy to interpret. The measured BRET ratio is the average
of the BRET ratios of the discrete donor molecules. The BRET
ratio of one donor molecule can be interpreted as the average time
spent by this donor molecule in the molecular proximity of the
acceptor molecules. Increasing the number of acceptor molecules
increases this time, so also the BRET ratio. When the number of
donor molecules increases, the average time spent by one donor
molecule in the molecular proximity of acceptors does not change,
so the BRET ratio is not dependent on the number of donor
molecules. In the case of specific interaction, the curve is steeper,
and the increase in donor amount leads to the flattening of the
curve (Fig. 2B, right panel). When the number of donor molecules
increases, more donor molecules do not form dimers with
acceptors, so the flattening of the curve is easy to interpret.
Alternatively, specific and non-specific interaction is also
distinguishable, when the data points are not separated by donor
amount, and a one-site specific binding curve is fitted on the
acceptor/donor ratio – BRET plots (Fig. 2C, black dashed line).
In this case, a reasonable curve fitting is possible for specific
interaction (R2.0.9), but not for non-specific interaction (R2,
0.5). However, for the reasons discussed above, this analysis needs
a larger amount of data points with ideal acceptor-donor
distribution (Figure S1), hence the reason for us not favoring its
use in the latter GPCR dimerization experiments.
To experimentally validate the results of our simulation we
studied the rapamycin inducible dimerization of plasma mem-
brane targeted FKBP and FRB protein domains. Although many
controls have been used previously for qBRET experiments,
including known interacting and non-interacting proteins, to our
knowledge our results are the first attempt to demonstrate the
relevance of qBRET curves in an inducible dimerization system.
The clear advantage of this system is that the investigated proteins
and their quantities are identical during the non-specific and
specific interaction. It is also important, that these proteins are
both plasma membrane expressed, thus they are better controls for
GPCR dimerization than cytoplasmic proteins that are also used
in earlier studies. Our experimental results showed nice correlation
with the simulations (Fig. 3C and 3D).
Based on our findings we propose a new methodical approach
to qBRET experiments, where various amounts of donor and
acceptor constructs are expressed, and the BRET ratio is plotted
as a function of the acceptor expression. With these changes, we
could clearly distinguish specific and non-specific interactions
(Fig. 2B and 3C). In our experiments, we confirmed the previously
described homodimerization of V2 vasopressin [30–33] (Fig. 4B)
and CaSR calcium sensing receptors [34–38] (Fig. 4C), but found
no heterodimerization of these receptors with the GPCRs
investigated in our study. These data indicate that the dimeriza-
tion of GPCRs is a rather specific phenomenon, as we found only
two receptor pairs (the two homodimers) to form dimers out of the
total twelve investigated receptor pairs. It is important to state that
using the classical interpretation of qBRET experiments, our data
suggested that V2R has similar affinity to form dimers with AT1R,
b2AdR, CB1R and V2R (Fig. 1B, left panel and Table 1), whereas
analysis of these interactions based on our new methodology
clearly showed that only the V2R-V2R interaction is specific
(Fig. 4B).
In this article, we showed that classical qBRET experiments can
lead to false results, when the expression of donor labeled receptor
is not held strictly constant. Of course, our findings do not mean
that all results obtained in previous qBRET experiments are
incorrect, since when donor expression falls with increasing
acceptor expression levels specific interaction also leads to
saturation qBRET curves (Fig. 2D). However, in many cases
non-specific interactions can lead to saturation qBRET curves,
because donor expression can decrease, when the acceptor
expression is increased. Since this problem can lead to false
positive interpretation of GPCR dimerization interactions, we
suggest that interpretation of earlier qBRET experiments should
be reconsidered (Fig. 5). In conclusion, our data suggest that
expression of the donor construct must be closely monitored
during qBRET analysis of GPCR dimers, and our method
provides a solution to exclude misinterpretation of the data caused
by alterations of donor receptor expression.
Supporting Information
Figure S1 Type I plots outperform Type II plots in detecting
non-specific interaction: Based on our simulations and inducible
dimerization experiments, we propose two different analysis
methods for qBRET experiments. Both methods require a wide
range of different levels of donor and acceptor expressions (left
panels). In the first method (Type I plots, middle panel) BRET
ratio is plotted as a function of acceptor expression, and the
difference between the slope of linear regression for points with
low and high donor amount is investigated. In the second method
(Type II plots, right panel) BRET ratio is plotted as a function of
acceptor/donor ratio, and one-site specific binding curve is fitted
on the whole data. Good (R2.0.8) fit suggests specific interaction,
while non-specific interaction results in a worse (R2,0.5) fit. To
investigate the performance of these two methods, we performed
additional Monte Carlo simulations. Simulations were ran with
random acceptor and donor amount (in the [100:1000] range) and
with simulation parameters for non-specific interaction. After the
simulation a random Gaussian noise term was added to the
acceptor, donor and BRET values to further approximate our
experimental setup. Simulations were performed for n= 100 (A) or
n = 20 (B) data points. When data sample is sufficiently large (A)
both methods showed the non-specific nature of interaction.
However, with smaller sample size, but still with a wide range of
different donor-acceptor amounts (B, left panel), it is possible to get
such a distribution of data points, where in Type II plots (B, right
panel) a reasonable saturation curve can be fitted (suggesting
specific interaction). In this case Type I plot still shows correctly
the non-specific nature of this interaction. Based on these data, we
think that when the data sample is not very large (,100 points),
Type I plots can better differentiate between specific and non-
specific interaction.
(PDF)
Figure S2 Fluorescence-Luminescence, Type I and Type II
plots of GPCR dimerization experiments: HEK293 cells were
transfected with various amounts of different donor and acceptor
coding plasmids. Measured points were sorted into low/high
luminescence groups based on the total measured luminescence
(red: low luminescence, blue: high luminescence). Fluorescence-
Luminescence (left), Fluorescence-BRET ratio (middle) and
Intensity ratio-BRET ratio (right) plots were created for different
donor-acceptor pairs. Summary of this plot can be found in
Figure 4B and 4C.
(PDF)
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